...
首页> 外文期刊>Journal of Medicinal Chemistry >Insight into the Structural Requirements of Urokinase-Type Plasminogen Activator Inhibitors Based on 3D QSAR CoMFA/CoMSIA Models
【24h】

Insight into the Structural Requirements of Urokinase-Type Plasminogen Activator Inhibitors Based on 3D QSAR CoMFA/CoMSIA Models

机译:基于3D QSAR CoMFA / CoMSIA模型的尿激酶型纤溶酶原激活剂抑制剂的结构要求的洞察

获取原文
获取原文并翻译 | 示例

摘要

Urokinase-type plasminogen activator (uPA),a trypsin-like serine protease,has been implicated in large number of malignancies,tumor cell invasion,angiogenesis and metastasis; hence,the potent and selective inhibitors of uPA may therefore be therapeutically useful drugs for treatment of various forms of cancer.A three-dimensional quantitative structure-activity relationship (3D QSAR) study was performed on five different chemical series reported as selective uPA inhibitors employing comparative molecular field analysis (CoMFA)/comparative molecular similarity indices analysis (CoMSIA) techniques to investigate the structural requirements for substrates and derive a predictive model that may be used for the design of novel uPA inhibitors.ClogP has been used as an additional descriptor in the CoMFA analysis to study the effects of lipophilic parameters on activity.Inclusion of ClogP did not improve the models significantly and exhibited comparable correlation coefficients with CoMFA steric and electrostatic models.3D QSAR models were derived for 2-pyridinylguanidines (training set N = 25,test set N = 8),4-aminoarylguanidines and 4-aminoarylbenzamidines (training set N = 29,test set N = 8),thiophene-2-carboxamindines (training set N = 64,test set N = 19),2-naphthamidines (training set N = 32,test set N = 8),and 1-isoquinolinylguanidines (training set N = 29,test set N = 7).The CoMFA models with steric and electrostatic fields exhibited r~2_(cv) 0.452-0.722,r~2_(ncv) 0.812-0.986,r~2_(pred) 0.597-0.870,whereas CoMFA ClogP models showed r~2_(cv) 0.420-0.707,r~2_(ncv) 0.849-0.957,r~2_(pred) 0.600-0.870.The CoMSIA models displayed r~2_(cv) 0.663-0.729,r~2_(ncv) 0.909-0.998,r~2_(pred) 0.554-0.855.3D contour maps generated from these models were analyzed individually,which provides the regions in space where interactive fields may influence the activity.The superimposition of contour maps on the active site of serine proteases additionally helps in understanding the structural requirements of these inhibitors.Further,the predictive ability of 3D QSAR models was affirmed by predicting the activity of novel 2-naphthamidines.3D QSAR models developed may be used in designing and predicting the uPA inhibitory activity of novel molecules.
机译:尿激酶型纤溶酶原激活剂(uPA)是一种胰蛋白酶样的丝氨酸蛋白酶,与大量恶性肿瘤,肿瘤细胞侵袭,血管生成和转移有关。因此,uPA的强效和选择性抑制剂可能是治疗各种形式癌症的治疗有用药物。针对报道的五种不同化学系列进行了三维定量构效关系(3D QSAR)研究比较分子场分析(CoMFA)/比较分子相似性指数分析(CoMSIA)技术研究底物的结构要求并推导出可用于设计新型uPA抑制剂的预测模型。进行CoMFA分析以研究亲脂性参数对活性的影响.ClogP的加入并没有显着改善模型,并且显示了与CoMFA空间和静电模型相当的相关系数。得出了2-吡啶基胍的3D QSAR模型(​​训练集N = 25,测试集N = 8),4-氨基芳基胍和4-氨基芳基苯甲m ng组N = 29,测试组N = 8),噻吩2-羧酰胺(训练组N = 64,测试组N = 19),2-萘啶(训练组N = 32,测试组N = 8),以及1-异喹啉基胍(训练组N = 29,测试组N = 7)。具有空间和静电场的CoMFA模型显示r〜2_(cv)0.452-0.722,r〜2_(ncv)0.812-0.986,r〜2_( pred)0.597-0.870,而CoMFA ClogP模型显示r〜2_(cv)0.420-0.707,r〜2_(ncv)0.849-0.957,r〜2_(pred)0.600-0.870.CoMSIA模型显示r〜2_(cv) )分别分析了从这些模型生成的0.663-0.729,r〜2_(ncv)0.909-0.998,r〜2_(pred)0.554-0.855.3D等高线图,从而提供了空间中相互作用场可能影响活动的区域。等高线图在丝氨酸蛋白酶活性位点上的叠加还有助于理解这些抑制剂的结构要求。此外,通过预测新型2-萘啶的活性来肯定3D QSAR模型的预测能力。可用于设计和预测新型分子的uPA抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号